News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Alana Cattapan & Françoise Baylis, The Star [Toronto] | 04.09.2016
Untitled Document

Every so often people complain about a shortage of sperm donors in Canada. For example, Liberal MP Anthony...

By Eram Agha, The Times of India | 04.09.2016
Untitled Document

ALIGARH: In spite of grieving the loss of their two unwed sons, a couple in their early 50's...

By Amy Schaeffer, The Inquisitr | 04.09.2016
Untitled Document

While most people aren’t extremely concerned about what gender child they have, it’s becoming more and more important...

Keiko Fujimori
By Manuel Rueda, Fusion | 04.08.2016
Untitled Document

LIMA, Peru – A group of young women hike up their skirts and smear each other’s inner thighs...

By Lee Fang, The Intercept | 04.08.2016
Untitled Document

SKINCENTIAL SCIENCES, a company with an innovative line of cosmetic products marketed as a way to erase blemishes and soften skin...

By Ewen Callaway, Nature News | 04.08.2016
Untitled Document

Researchers in China have reported editing the genes of human embryos to try to make them resistant to...

By Denise Grady, The New York Times | 04.08.2016
Untitled Document

Just two weeks after receiving the first uterus transplant in the United States, a patient at the...

By David Jensen, Capitol Weekly | 04.08.2016
Untitled Document

Directors of California’s stem cell agency this morning approved financing terms for a proposed, $150 million, public-private company...